Drugmaker Merck buys Swiss biotech with promising experimental drug for tumors, blood cancers

Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas.